Navigation Links
4th International Nanomedicine Conference
Date:6/24/2013

The Australian Centre for Nanomedicine (ACN) at UNSW is hosting the fourth International Nanomedicine Conference from 1 3 July in Sydney.

The conference will bring together world-leading experts to highlight research into new drugs, targeted drug delivery systems, diagnostics and imaging, and regenerative medicine.

The ACN is an interdisciplinary research centre comprising UNSW scientists, engineers and clinicians who are working together to develop new treatments that could deliver a mighty blow in the fight against currently incurable diseases, including a range of chemo-resistant cancers.

Nanomedicine involves the development of new treatment and detection strategies in medicine that arise from nanotechnology, such as the synthesis of nano-sized particles that have been engineered to perform a very specific function inside the body.

One nanometre is equivalent to one-billionth of a metre and is roughly 60,000 times thinner than a human hair. A single strand of DNA is just three nanometres wide.

At this sub-microscopic scale, materials sometimes exhibit curious physical, chemical and biological properties. These can be exploited to create particles that release drugs in a highly controlled way or to develop sensors that can provide early detection of disease.

Keynote speakers include:

  • Heather Maynard, Director of the Chemistry Biology Interface Training Program at UCLA
  • John Mattick, Director of the Garvan Institute of Medical Research in Sydney
  • Scott McNeil, Director of the Nanotechnology Characterization Lab in Maryland, US

Things to watch from the Australian Centre for Nanomedicine at UNSW:

Researchers have begun work on a new drug that will target chemo-resistant pancreatic cancer. The objective is to break down and halt the spread of the cancer cells, and to simultaneously "switch off" genes associated with its development. Professor Maria Kavallaris, Co-Director of the Centre, says there are certainly "future applications across a range of cancers".

  • Phoebe Phillips from UNSW Medicine will speak about this work

UNSW researchers have teamed up with Sydney-based biotech company Benitec Biopharma to develop a "gene silencing" technology that has been shown in preclinical models to dramatically improve the effectiveness of chemotherapy in lung cancer.

  • Michael Graham, Chief Scientist at Benitec Biopharma, will speak about this work and how the company's unique gene silencing approach can target other diseases such as hepatitis C.

Event Details:

What: 4th Annual International Nanomedicine Conference
Where: Intercontinental Hotel, 117 Macquarie Street, Sydney CBD
When: 1-3 July 2013
Register online and see the full list of speakers at: http://www.oznanomed.org/


'/>"/>

Contact: Myles Gough
myles.gough@unsw.edu.au
61-407-061-209
University of New South Wales
Source:Eurekalert

Related biology news :

1. PETA International Science Consortium disappointed in denial of Dow appeal
2. First international collaboration to showcase latest body of evidence of dairy health benefits
3. SPIE on global team proposing International Year of Light at United Nations
4. CLEO: 2013 -- the Premier International Laser and Electro-Optics Event in San Jose next week
5. New review sets international standards for best practice in fracture liaison services
6. BGI hosts its 2nd International Conference on Genomics in the Americas
7. Drive-Up Biometric System from SRI International Sarnoff Wins New Product Showcase Award at ISC West 2013
8. International conference will put agri-food supply chain under the microscope
9. International collaboration to investigate disappearing reptiles and amphibians
10. International conference to tackle climate-change threats to agriculture
11. International study: Excess dietary salt may drive the development of autoimmune diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... fourth quarter and year ended December 31, 2015.  ... of 2015 was $6.9 million, an increase of 61% compared to ... the fourth quarter of 2015 was $2.6 million compared to $0.2 ... --> --> Higher revenue and operating income in ...
(Date:2/8/2016)... February 8, 2016 Worldcore ... which presents innovation for clients, comfort and unbeatable ... VoiceKey. --> Worldcore is the ... for clients, comfort and unbeatable security, with a ... Worldcore is the first EU-regulated ...
(Date:2/4/2016)... 2016 The field of Human Microbiome ... most popular hubs of the biotechnology industry. While ... studies of human microbiota, have garnered a lot ... microbiome space has literally exploded in terms of ... report focuses on biomedical aspects of research, development, ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... Springfield, MO (PRWEB) , ... February 10, 2016 ... ... company, will attend the International Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter ... of ISPE is expecting to fill more than 100 tables for its annual ...
(Date:2/10/2016)... ... February 10, 2016 , ... Curoverse ... Azure. On Azure, Arvados provides capabilities for managing and processing genomic and health ... Azure from major institutions collecting and analyzing genomic data,” said Adam Berrey chief ...
(Date:2/9/2016)... ... February 09, 2016 , ... With a presidential election in ... Care Business Conference will bring together over 500 top healthcare leaders for a night ... transformation. The conference, organized by MBA students of the University of Pennsylvania’s Wharton School, ...
(Date:2/9/2016)... ... February 09, 2016 , ... Clinovo , the cloud-based ... Electronic Data Capture (EDC) system ClinCaptureand its new Contract Research Organization (CRO) Partner ... Conference in San Mateo, California on February 10th and 11th. Watch 2-min ...
Breaking Biology Technology: